HEALTHglobal
STAT+: Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says
Single source
Updated 2 hours ago
First seen March 17, 2026 17:28:56Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial financial and treatment problems, according to a new report.